Immunotherapy
Links shared publicly online about this topic.
- 1,188total visits
Immunotherapy
View full resource at atlantaallergydoctor.com
Tags: Allergy and Immunology, Allergies, Seasonal Allergy, Asthma, Sinusitis, Cough, Children's Health
Most Recently Shared on May 6, 2010 at 3:52 pm By:
How effective are allergy shots? http://dld.bz/ceqM Anyone care to share their experiences with these shots?
Advaxis Announces Abstracts Accepted for Poster Presentation at AACR Annual Meeting 2012 - Drugs.com MedNews
drugs.com — “Mar 28, 2012 - Advaxis, Inc., (OTCBB ADXS), a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced that two” View full resource at drugs.com
Most Recently Shared on March 28, 2012 at 11:08 pm By:
Drugs and Devices OW OW Health
Lilly's Anti-IL-17 Monoclonal Antibody, Ixekizumab, Met Primary Endpoint in Phase II Study in Patients Wit... http://t.co/oQaYeZ3k #drug
Advaxis Announces Abstracts Accepted for Poster Presentation at AACR Annual Meeting 2012 - Drugs.com MedNews
drugs.com — “Mar 28, 2012 - Advaxis, Inc., (OTCBB ADXS), a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced that two” View full resource at drugs.com
Most Recently Shared on March 28, 2012 at 3:16 pm By:
Drugs and Devices OW OW Health
Advaxis Announces Abstracts Accepted for Poster Presentation at AACR Annual Meeting 2012: PRINCETON, N.J.-... http://t.co/XWYVz05X #drug
Advaxis Announces Abstracts Accepted for Poster Presentation at AACR Annual Meeting 2012 | BioPortfolio.com
bioportfolio.com — “From BioPortfolio: Advaxis, Inc., (OTCBB: ADXS), a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced that two abstracts hav...” View full resource at bioportfolio.com
Most Recently Shared on March 28, 2012 at 2:01 pm By:
BioPortfolio News Advaxis Announces Abstracts Accepted for Poster Presentation at AACR Annual ... http://t.co/HhV298gu BioPortfolio News
Allergy Immunotherapy | Allergy Shots | ACAAI
acaai.org — “Allergy Immunotherapy | Allergy Shots | ACAAI” View full resource at acaai.org
Most Recently Shared on March 27, 2012 at 5:45 pm By:
T4 #allergy shots http://t.co/f2O1BLKZ are only treatment that alters #allergies for more than just symptom relief.#ABCDrBchat
Pox vaccines extend survival for patients with melanoma, ovarian cancer
medicalxpress.com — “An immunotherapy regimen incorporating poxviruses and targeting a particular tumor antigen, NY-ESO-1, has shown promise in treating two types of cancers. Kunle Odunsi, MD, PhD, Chair of the Department of Gynecologic Oncology and Director of the Center for Immunotherapy at Roswell Park Cancer Institute ...” View full resource at medicalxpress.com
Most Recently Shared on March 26, 2012 at 10:20 pm By:
PhysOrg Health News Health News
Pox vaccines extend survival for patients with melanoma, ovarian cancer http://t.co/nohDd8u7
Pox Vaccines Extend Survival for Patients with Melanoma, Ovarian Cancer in U.S., German Studies
newswise.com — “Researchers from Roswell Park Cancer Institute, Krankenhaus Nordwest and two other institutions have published results of parallel phase II studies testing a promising immunotherapy regimen in patients with melanoma and ovarian cancer” View full resource at newswise.com
Most Recently Shared on March 26, 2012 at 8:27 pm By:
Pox Vaccines Extend Survival for Patients with Melanoma, Ovarian Cancer in U.S., German Studies: Researchers fro... http://t.co/gdLC2pTA
Guideline: IVIg Effective for Certain Nerve and Muscle Disorders -- American Academy of Neurology
aan.com — “Intravenous immune globulin (IVIg) is an effective treatment for certain disorders of the nerve and muscles , including Guillain-Barré syndrome (GBS) and a form of neuropathy called chronic inflammatory demyelinating polyneuropathy (CIDP), according to a guideline issued by the American Academy of Neurology. The guideline is published in the March 27, 2012, print issue of Neurology®, the medical journal of the American Academy of Neurology . IVIg is a type of immunotherapy that fights ” View full resource at aan.com
Most Recently Shared on March 26, 2012 at 8:04 pm By:
Neurology Today Neurology and Medical Journal
New AAN guidelines on IVIg: http://t.co/midIIZA8. Look for our... http://t.co/0ijvhwJF
Immunomodulatory Drugs and Active Immunotherapy for CLL - QualityPoint Technologies
qualitypointtech.net — “The vast majority of patients with relapsed or refractory CLL carry poor prognostic features, but immunomodulatory drugs and active immunotherapy may be an option for some. Cancer Control: Journal of the Moffitt Cancer Center” View full resource at qualitypointtech.net
Most Recently Shared on March 26, 2012 at 11:00 am By:
Immunomodulatory Drugs and Active Immunotherapy for CLL: The vast majority of patients with relapsed or refractory... http://t.co/WmGeBktI
Can Allergy Shots Cut Asthma Risk? - YouTube
youtube.com — “Can allergen-specific immunotherapy cut the risk of asthma development in children with allergic rhinitis? Dr. Linda Cox discusses the potential implications...” View full resource at youtube.com
Most Recently Shared on March 23, 2012 at 5:57 pm By:
Can Allergy Shots Cut Asthma Risk? http://t.co/KBCHFJdQ
Allergen Immunotherapy | Children with Allergic Rhinitis
acaai.org — “Allergen Immunotherapy | Children with Allergic Rhinitis” View full resource at acaai.org
Most Recently Shared on March 23, 2012 at 5:11 pm By:
Kids who get #allergy shots for nasal allergies benefit from a disease-modifying treatment & lower healthcare bills http://t.co/2jMNBzHi
Table of contents : Nature Reviews Focus on Tumour immunology and immunotherapy
nature.com — “Table of contents : Nature Reviews Focus on Tumour immunology and immunotherapy” View full resource at nature.com
Most Recently Shared on March 23, 2012 at 11:30 am By:
Anas Younes, M.D. Physician, Doctor, Internist, and Oncologist
Wonderful RT @NatureRevCancer: Focus on Tumour immunology in @NatRevImmunol for some #weekendreading http://t.co/Jpqh8JQA
Immunology and Cell Biology - Regulatory T cells fulfil their promise[quest]
nature.com — “Immunology and Cell Biology focuses on the general functioning of the immune system in its broadest sense, with a particular emphasis on its cell biology. Areas that are covered include but are not limited to: Cellular immunology, Innate and adaptive immunity, Immune responses to pathogens,Tumour immunology,Immunopathology, Immunotherapy, Immunogenetics, Immunological studies in humans and model organisms (including mouse, rat, Drosophila etc)” View full resource at nature.com
Most Recently Shared on March 23, 2012 at 9:39 am By:
Juan C. Ivancevich, MD Doctor, Internist, Allergist, and Physician
Regulatory T cells fulfil their promise? http://t.co/3WTYZRQD
A comparison of attrition rates in ... [Int Forum Allergy Rhinol. 2012] - PubMed - NCBI
ncbi.nlm.nih.gov — “PubMed comprises more than 21 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on March 22, 2012 at 9:34 pm By:
John Weiner Doctor, Internist, Allergist, and Physician
No difference in attrition rate for allergen immunotherapy of injections (SCIT) vs oral (SLIT) http://t.co/EDLE78kk
Coronado Biosciences Signs Collaboration Agreement With Dr. Falk Pharma and OvaMed for the Development of TSO for Crohn's Disease - Yahoo! Finance
finance.yahoo.com — “From Yahoo! Finance: BURLINGTON, Mass. -- Coronado Biosciences, Inc. , a biopharmaceutical company focused on the development of novel immunotherapy agents for the treatment of autoimmune diseases and cancer, today announced ...” View full resource at finance.yahoo.com
Most Recently Shared on March 22, 2012 at 11:52 am By:
Crohn Disease Wisdom OW Health
Coronado Biosciences Signs Collaboration Agreement With Dr. Falk Pharma and OvaMed for the Development of TSO fo... http://t.co/j8NjJfbq
Special Report on Immunotherapy: Managing Yervoy's Side Effects
onclive.com — “As an immunotherapy, Yervoy presents a unique set of side effects and it was approved along with a Risk Evaluation and Mitigation Strategy to address these events.” View full resource at onclive.com
Most Recently Shared on March 21, 2012 at 8:58 pm By:
Special Report on Immunotherapy: Managing Yervoy's Side Effects http://t.co/YF1FeNxM
Advertisement
